We are using cookies in order to offer you the most relevant information. We have published
new Cookie Policy which you should read to find out more. more.
Please accept cookies for optimal performance.

Now Medical Device startups and small businesses that use Jira can be connected to qmsWrapper. This integration will help medical device companies reduce their development risks and increase their agile effectiveness, whilst still keeping an eye on quality.

“qmsWrapper got its name because it originally designed to ‘wrap’ Jira in a QMS blanket, to take advantage of the best Agile development system and combine it, “wrap” it together with the best QMS system”

Drazenka Z. project manager

qmsWrapper integrates with Jira software

 

qmsWrapper is designed to be wrapped around Jira. This extends the benefits of Jira in the medical device world. Medical Devices startups and small businesses that use Jira can be linked to qmsWrapper.

 

Integration means better control of the development process.

 

The combination of Jira with qmsWrapper brings a system in which medical device manufacturers are able to track, manage and organize all CE Technical Files and FDA Design History Files,

 and do it in the most effective manner possible.

This integration will help medical device companies reduce their development risks and increase their agile effectiveness, whilst still keeping an eye on quality.

 

Integration with Jira adds 3 main advantages:Jira with Quality

 

  1. Projects created in Jira are visible in qmsWrapper, they are connected.
  2. Issues created in Jira can be seen in qmsWrapper and tracked in Traceability Matrix.
  3. Connects a risk identified through Jira issues in the Traceability Matrix in a risk-related column.

 

Start integration with JiraSetting Jira integration with qmsWrapper

  1. General settings
  2. Jira integration
  3. Fill up the form
  4. Click “save integration”

qmsWrapper screenshots: Jira integration

Jira integrates with qmsWrapper

Comments (0)

*your email will not be published

No comments.